tradingkey.logo

Charles River Laboratories International Inc

CRL
189.210USD
+5.510+3.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
9.31BCap. mercado
PérdidaP/E TTM

Charles River Laboratories International Inc

189.210
+5.510+3.00%

Más Datos de Charles River Laboratories International Inc Compañía

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Información de Charles River Laboratories International Inc

Símbolo de cotizaciónCRL
Nombre de la empresaCharles River Laboratories International Inc
Fecha de salida a bolsaJun 23, 2000
Director ejecutivoFoster (James C)
Número de empleados18600
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 23
Dirección251 Ballardvale St
CiudadWILMINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal01887
Teléfono17812226000
Sitio Webhttps://www.criver.com/
Símbolo de cotizaciónCRL
Fecha de salida a bolsaJun 23, 2000
Director ejecutivoFoster (James C)

Ejecutivos de Charles River Laboratories International Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
292.33K
+24367.00%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
64.16K
+6439.00%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+5856.00%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
16.05K
+3169.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.08K
-1600.00%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+946.00%
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Independent Director
Independent Director
3.96K
+946.00%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
2.59K
+1576.00%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
2.41K
+946.00%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
946.00
+946.00%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
292.33K
+24367.00%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
64.16K
+6439.00%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+5856.00%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
16.05K
+3169.00%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.08K
-1600.00%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+946.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Por negocioUSD
Nombre
Ganancia
Proporción
DSA
600.68M
59.78%
RMS
213.47M
21.24%
Manufacturing
190.69M
18.98%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
537.61M
53.50%
Europe
277.69M
27.63%
Canada
116.81M
11.62%
Asia Pacific (Region)
51.66M
5.14%
Other
21.08M
2.10%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
DSA
600.68M
59.78%
RMS
213.47M
21.24%
Manufacturing
190.69M
18.98%

Estadísticas de accionistas

Actualizado: sáb., 27 de dic
Actualizado: sáb., 27 de dic
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.94%
Wellington Management Company, LLP
6.48%
BlackRock Institutional Trust Company, N.A.
5.73%
Allspring Global Investments, LLC
4.05%
State Street Investment Management (US)
3.72%
Otro
68.07%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.94%
Wellington Management Company, LLP
6.48%
BlackRock Institutional Trust Company, N.A.
5.73%
Allspring Global Investments, LLC
4.05%
State Street Investment Management (US)
3.72%
Otro
68.07%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
45.68%
Investment Advisor
44.83%
Hedge Fund
7.70%
Research Firm
4.25%
Bank and Trust
2.87%
Pension Fund
1.52%
Individual Investor
1.14%
Sovereign Wealth Fund
1.04%
Family Office
0.09%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1367
52.25M
129.09%
+28.56K
2025Q3
1413
52.22M
129.54%
+64.86K
2025Q2
1411
52.12M
127.74%
-2.86M
2025Q1
1414
54.69M
123.53%
-5.98M
2024Q4
1410
54.25M
114.75%
+1.17M
2024Q3
1372
53.38M
114.53%
-33.66K
2024Q2
1378
53.46M
111.45%
+347.48K
2024Q1
1371
53.18M
111.09%
-4.05M
2023Q4
1405
52.96M
112.24%
-202.82K
2023Q3
1421
52.99M
111.08%
+631.82K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
5.83M
11.84%
+27.29K
+0.47%
Sep 30, 2025
Wellington Management Company, LLP
3.19M
6.48%
-577.34K
-15.32%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.82M
5.73%
+69.84K
+2.54%
Sep 30, 2025
Allspring Global Investments, LLC
2.18M
4.43%
-113.19K
-4.94%
Sep 30, 2025
State Street Investment Management (US)
1.83M
3.72%
-27.63K
-1.49%
Sep 30, 2025
Ariel Investments, LLC
1.49M
3.03%
+74.75K
+5.28%
Sep 30, 2025
Harris Associates L.P.
1.47M
2.99%
+310.15K
+26.67%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.27M
2.57%
+34.52K
+2.80%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.13M
2.3%
+120.21K
+11.89%
Sep 30, 2025
Invesco Capital Management LLC
1.10M
2.24%
+10.09K
+0.92%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco S&P 500 Equal Weight Health Care ETF
1.92%
Schwab Ariel Opportunities ETF
1.82%
iShares Health Innovation Active ETF
1.74%
First Trust NASDAQ Pharmaceuticals ETF
1.71%
ROBO Global Healthcare Technology & Innovation ETF
1.69%
VanEck Biotech ETF
1.44%
Franklin Genomic Advancements ETF
1.42%
WisdomTree US Value Fund
1.15%
Invesco S&P 500 High Beta ETF
1.14%
Pacer Lunt Large Cap Alternator ETF
0.97%
Ver más
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.92%
Schwab Ariel Opportunities ETF
Proporción1.82%
iShares Health Innovation Active ETF
Proporción1.74%
First Trust NASDAQ Pharmaceuticals ETF
Proporción1.71%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.69%
VanEck Biotech ETF
Proporción1.44%
Franklin Genomic Advancements ETF
Proporción1.42%
WisdomTree US Value Fund
Proporción1.15%
Invesco S&P 500 High Beta ETF
Proporción1.14%
Pacer Lunt Large Cap Alternator ETF
Proporción0.97%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI